AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

Astellas Pharma US, Inc., is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Located in Northbrook, Illinois, the company serves as the headquarters for the Americas and employs nearly 3,000 people. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. The life-changing scientific breakthroughs Genentech has delivered over the last five decades stand as a testament to this patient-first philosophy. However, we are not resting on our legacy; we are building on it. Genentech is now leading the next revolution in human health, ensuring we remain at the forefront of scientific progress for the next 50 years. Today, we are pioneering the integration of AI and data science into every facet of drug discovery and patient care. Our longevity is a direct result of fostering an entrepreneurial culture where intellectual curiosity, cross-disciplinary collaboration, and the courage to take scientific risks are not just encouraged—they are mandated. This unique environment ensures that the innovation pipeline remains robust and disruptive. We believe a great people experience is critical for revolutionizing healthcare and living Our Promise. That’s why we’re committed to cultivating an environment where people feel valued, included and able to thrive.

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

https://x.com/Merck

https://www.linkedin.com/company/merck

Peterson Health Analytics (PHA) is a public-benefit company, built to empower employers with independent, actionable data analysis of healthcare costs and quality. PHA operates without financial ties to health plans, health systems or benefits consultants, ensuring its analysis is free from conflicts of interest. By combining price transparency data, employer claims data, and independent quality and safety ratings, PHA enables employers to benchmark and reset their healthcare spending to deliver more affordable and higher-quality care for workers and their families. PHA was established by Peterson Philanthropies in 2026.

Renalogic is dedicated to reducing the cost and improving the outcomes of kidney disease and related specialty care. Founded in 2002, Renalogic has spent more than 20 years building a suite of solutions that help self-insured employers and health plans manage the financial and clinical burden of chronic kidney disease (CKD), end-stage renal disease (ESRD), oncology, and specialty infusion therapy.

Senderra Specialty Pharmacy is a national, independent, full-service pharmacy in the U.S., dedicated to patient-centered care and innovative solutions. With over 900 employees, we lead the industry by delivering life-changing support to patients with chronic and complex conditions. Through proprietary technology and collaboration with our patients, healthcare providers, payers, and pharmaceutical manufacturers, we achieve superior patient outcomes. Our Clinical and National Field Support teams offer personalized assistance, while our funding team ensures financial accessibility. Additionally, we have state-of-the-art pharmacy distribution centers enhancing our capacity to meet the growing demand for specialized care.

The Alliance for Women’s Health & Prevention (AWHP) is a nonprofit organization working to ensure that all women and girls have access to high-quality preventive care. Our mission is to advance policy that drives equitable access and prevents the burden and progression of disease to improve the lives and health of all women and girls.

One of AWHP’s signature initiatives is the EveryBODY Covered campaign, a national effort focused on expanding coverage of comprehensive obesity care. Obesity is a chronic disease affecting approximately one in three American women, yet insurance coverage for evidence-based obesity care continues to fall short.

EveryBODY Covered brings together more than 30 national partner organizations and 100,000 advocates to make the case for change. The campaign empowers women to raise their voices with policymakers and employers, advocates for expanded coverage at the state and federal levels and works to ensure obesity is treated like any other chronic disease.

Through EveryBODY Covered, AWHP is leading a movement to ensure that more women can access the full range of obesity care options they need and deserve.

Color has reinvented the approach to cancer and created a single partner for accessible, clinical care across the entire cancer journey. By focusing on three main levers—access, speed, and direct clinical care—Color’s ASCO-certified, oncologist-led team identifies and manages your high-risk members no matter where they live, detects cancer earlier, improves clinical outcomes and costs for those in active treatment, and keeps survivors healthy to minimize recurrence. This cancer command center approach drives enrollment of 20%, increases screening adherence by 77%, cuts time to diagnosis and treatment by 66%, closes >75% of clinical care gaps, saves $62k on average per patient in treatment, and delivers 3.8:1 ROI in year one.

Ferring Pharmaceuticals is a privately-owned, specialty biopharmaceutical group committed to building families and helping people live better lives. In the United States, Ferring is a leader in reproductive medicine and in the areas of gastroenterology and orthopaedics. We are at the forefront of innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Ferring employs more than 7,000 people worldwide and markets its medicines in more than 100 countries. Ferring has been pioneering advancements in reproductive medicine for more than 50 years - from our well-studied product portfolio that has decades of real-world experience, to educational resources for healthcare professionals and aspiring parents, to our work to expand access to care. In fact, right now globally, at least one baby is born every three minutes with the help of our reproductive medicines. Our mission is to help more people become parents. For more information, please visit www.ferringusa.com or connect with us on LinkedIn.

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of patients with critical and chronic conditions. With more than 41,000 employees and present in more than 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to essential medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. Fresenius Kabi takes a holistic approach to health care and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is part of the Fresenius Group, founded in 1912. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. For more information, please visit www.fresenius-kabi.com/us. To learn about U.S. career opportunities at Fresenius Kabi, visit us at www.fresenius-kabi.com/us/join-us and follow us on LinkedIn and Facebook.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation
empowers us to build a world where complex diseases are prevented, treated, and cured, where
treatments are smarter and less invasive, and solutions are personal. Through our expertise in
Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full
spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly
impact health for humanity. Learn more at https://www.jnj.com/ or at www.janssen.com/johnsonjohnson-innovative-medicine. Follow us at @JanssenUS and @JNJInnovMe

The Patient-Centered Outcomes Research Institute, or PCORI, is a nonprofit research funding organization that seeks to equip patients and those who care for them with actionable information to weigh the trade-offs of health and healthcare choices and make informed decisions that reflect their needs and preferences. PCORI funds patient-centered comparative clinical effectiveness research, or CER. This is research that compares the benefits and potential harms of established or broadly used treatments, clinical interventions or healthcare approaches to provide evidence that patients and other health decision makers can use. PCORI emphasizes the engagement of patients, caregivers and the broader healthcare community in all aspects of PCORI-funded research and research-related activities, including the dissemination and uptake of research findings

SmartLight Analytics helps self-funded plans reduce wasteful healthcare costs and enhance fiduciary oversight through advanced claims analysis and deep industry expertise. We combine proprietary AI with expert clinical review to uncover waste, errors, and overpayments across medical, pharmacy, and dental billing and payments. Our transparent, result-driven approach protects healthcare dollars without disrupting employee benefits. We deliver measurable savings and data-driven guidance to help employers manage plans more effectively.

Founded by research scientists and clinicians, TruDataRx is a pharmacy data analytics company that empowers self-insured employers with science-based solutions to reduce pharmacy spend. TruDataRx specializes in Comparative Effectiveness Research (CER) that combines biostatistics, clinical epidemiology, and decision science to evaluate clinical interventions and create evidence-based drug coverage policies. By evaluating medications on clinical efficacy rather than manufacturer rebates, TruDataRx ensures plan sponsors pay for true clinical value. We deploy our CER strategies through two offerings: 1) TruCardRx, our full-service and modular pharmacy benefit solution for self-insured employers, and 2) TruFormularyRx, our formulary management carveout solution for ultra-large employers that have already adopted a modular or PBA model. Through both solutions, our clients experience year-over-year net cost reductions of 20%–40% in the first year and lower-than-market trend in ongoing years.

finHealth specializes in detecting and resolving inaccurate and fraudulent health insurance charges. As an independent unbiased partner, we provide self-funded employers with greater visibility, transparency, and understanding of their health care spend to take action to reduce costs and improve accountability.  We are the industry leader in helping self-insured employers address all forms of healthcare waste and uphold their fiduciary responsibilities to plan members under ERISA.  We are dedicated to revolutionizing the healthcare industry by providing accurate and efficient solutions to protect both insurance providers and policy holders.

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people.

The Prism Health Group is an independent pharmacy and 340B consulting firm that helps employers, health systems, government entities, and health plans optimize pharmacy programs through procurement, audit, analytics, clinical strategy, and compliance solutions. Founded in 2020 and headquartered in Wayzata, MN, Prism serves more than 300 organizations representing over 5 million covered lives nationwide. With an unwavering commitment to independence and unbiased thought leadership, Prism delivers innovative, data-driven solutions that improve outcomes, reduce costs, and strengthen accountability across the pharmacy landscape.

Blue Genes is transforming how medicine is prescribed—by unlocking the power of pharmacogenetics. Our platform translates complex genetic insights into clear, actionable guidance at the point of care, helping providers understand how each patient’s unique DNA impacts their response to medications.
With every interaction, we reduce the risk of adverse drug reactions, aiming to cut them by 50%, and help avoid unnecessary or ineffective prescriptions. Through real-time integrations with health plans, pharmacy benefit managers, and clinical systems, we bring personalized prescribing into everyday practice—making precision medicine the new standard of care.
At Blue Genes, we’re building a future where treatment decisions are safer, faster, and deeply personal. Because when care is guided by genetics, everyone benefits.

Digbi Health is a digital health company providing personalized care for metabolic and inflammatory conditions, including obesity, diabetes, and digestive health. Digbi works with employers and health plans to improve health outcomes, increase engagement, and reduce the growing cost of chronic disease.

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. The Bayer brand stands for trust, reliability, and quality throughout the world.

Green Imaging offers direct diagnostic care to employers and members through our quality, easy, and affordable network across the United States. We are a great option for self-funded employers looking to buy healthcare directly from providers, often as a bolt-on benefit that easily co-exists with traditional and non-traditional employee benefits insurance. We offer a fast, no-cost assessment of claims and geographic analysis to determine if we would be a good fit for employers.

Northwell Direct is the leading direct-to-employer solution for the greater New York Metro. We deliver enhanced access and affordability through our high-value network of over 43,000 providers, at-the-bedside care management, and employee health and wellness services. Owned by Northwell Health, New York State’s largest health care provider, Northwell Direct brings together employers and providers to create innovative, affordable health benefit solutions that reduce costs and boost employee wellbeing.

Premise Health is the leading direct healthcare provider and one of the largest digital providers in the country, serving millions of members across commercial and municipal employers, health plans, unions, and tribes in the U.S. Premise’s integrated model of in-person and virtual care provides convenient, often same-day access to diverse member populations. It operates more than 800 onsite and nearsite wellness centers in 46 states and Guam, delivering care through onsite, nearsite, and virtual solutions.

With an innovative advanced primary care model, deep expertise in occupational health, and more than 30 types of care, Premise delivers the breadth and depth of care required to serve its partners’ total populations. The result is high-quality healthcare that meets the needs of members and their families, helping them live healthier while lowering costs for organizations. For more information on Premise Health, visit www.premisehealth.com.

SmithRx is revolutionizing the pharmacy benefits industry with a radically transparent, 100% pass-through model. As a modern PBM, we're dismantling the opaque practices that have long dominated the industry and driven up drug costs. SmithRx serves businesses of all sizes, from small local companies to large corporations, providing them with the tools and insights to make informed decisions about their pharmacy benefits. Unlike legacy PBMs, we operate on a fully transparent, aligned-incentive model, passing through 100% of rebates and discounts and eliminating hidden fees. By offering real-time prescription pricing and detailed savings reports, SmithRx empowers employers and members alike. Our commitment to transparency and fairness is setting new standards for the industry and paving the way for a more equitable healthcare system.

The Fuchsia Tent (TFT) is a national workplace menopause research and consulting organization. TFT builds evidence-based midlife support strategies and resources for employers, coalitions, and industry partners. Recent work includes national primary research conducted in partnership with the Society for Women's Health Research, the Cost of Inaction budget impact model, and the 3H Healthcare Access Audit. Each resource helps employers improve how employees access menopause care through existing benefits. The Fuchsia Tent was founded by Kacy Fleming, MA, Organizational Psychologist and former Head of Global Well-Being at Takeda Pharmaceuticals. Visit thefuchsiatent.com.

Our mission is to build a waste-free healthcare transaction—a cleaner, simpler interaction between providers, payers, and patients. We will leave the waste exhaust behind. We're here to replace ambiguity with clarity, fragmentation with standardization, and opacity with transparency. We believe the future is one where healthcare payments are predictable, explainable, and fast. Where a family can focus on healing instead of spreadsheets, and where "it depends" becomes the rare exception, not the operating system.

US-Rx Care is a clinical pharmacy organization providing fiduciary pharmacy risk management services to self-insured employers, union trust funds, and health plans of all sizes encompassing over 5 million insured individuals. We grew up in the at-risk health plan environment, working for and consulting to multiple Medicare, Medicaid, and commercial health insurers for over thirty years. At US-Rx Care, clients have access to proven pharmacy risk management programs and solutions that have consistently delivered reductions in pharmacy benefit spend by 30%-50% or more for at-risk health plan sponsors. We have also assisted multiple plans to achieve dramatic increases in HEDIS / Stars quality scores to achieve a 5-star rating under Medicare.

https://www.linkedin.com/company/usrxcare